D
Personalis, Inc. PSNL
$8.77 -$0.51-5.50% NASDAQ
Recommendation
Prev Close
$8.77
Volume
4,338,804
Avg Vol (90D)
1,257,817
Market Cap
$778.81M
Dividend & Yield
--
52-Week Range
$2.83 - $11.40
P/E (TTM)
--
EPS (TTM)
-$0.88
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Personalis (NASDAQ:PSNL) Sees Unusually-High Trading Volume - Still a Buy?
12/13/2025 - MarketBeat
Personalis (NASDAQ:PSNL) Sees Unusually-High Trading Volume - Still a Buy?
12/12/2025 - Ticker Report
New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
12/11/2025 - Business Wire
Personalis (PSNL, $9.26) Stochastic Oscillator left the oversold zone on December 09, 2025
12/10/2025 - Tickeron - Stocks
Personalis (PSNL, $9.26) entered Downtrend as Momentum indicator drops below 0 level on Dec 09, 2025
12/10/2025 - Tickeron - Stocks
Personalis (PSNL, $9.26) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 9, 2025
12/10/2025 - Tickeron - Stocks
Personalis (NASDAQ:PSNL) Stock Price Down 4.8% - What's Next?
12/6/2025 - MarketBeat
Personalis (NASDAQ:PSNL) Cut to Sell at Wall Street Zen
12/6/2025 - MarketBeat
Personalis (NASDAQ:PSNL) Stock Price Down 4.8% - What's Next?
12/5/2025 - Ticker Report
Geode Capital Management LLC Buys 851,422 Shares of Personalis, Inc. $PSNL
12/5/2025 - MarketBeat
Personalis (PSNL, $10.17) Stochastic Oscillator left the overbought zone on December 03, 2025
12/5/2025 - Tickeron - Technical Analysis
Analysts Set Personalis, Inc. (NASDAQ:PSNL) PT at $10.29
12/4/2025 - Ticker Report
Personalis (PSNL) Rating Maintained and Price Target Raised by Morgan Stanley PSNL Stock News
12/2/2025 - GuruFocus
Personalis (NASDAQ:PSNL) Shares Gap Down After Insider Selling
12/2/2025 - MarketBeat
Personalis assumed with an Equal Weight at Morgan Stanley
12/1/2025 - TipRanks Financial Blog
Personalis assumed with an Equal Weight at Morgan Stanley
12/1/2025 - The Fly
Personalis (NASDAQ:PSNL) Shares Gap Down After Insider Selling
12/1/2025 - Ticker Report
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), Dyadic International (DYAI) and NeurAxis, Inc. (NRXS)
12/1/2025 - TipRanks Financial Blog
Personalis, Inc. (NASDAQ:PSNL) Receives Average Rating of "Moderate Buy" from Brokerages
12/1/2025 - MarketBeat
Insider Selling: Personalis (NASDAQ:PSNL) CFO Sells 103,668 Shares of Stock
11/29/2025 - MarketBeat
Personalis (NASDAQ:PSNL) CFO Aaron Tachibana Sells 103,668 Shares
11/29/2025 - MarketBeat
Personalis Announces $100M Stock Offering Amendment
11/28/2025 - TipRanks Financial Blog
Insiders Of Personalis Make A Tidy Sum Selling At US$7.14
11/28/2025 - Simply Wall St
Personalis: A Growth Inflection Is Imminent, Hold
11/28/2025 - SeekingAlpha
Personalis (NASDAQ:PSNL) Stock Price Down 4.4% - Here's What Happened
11/27/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$69.10M
EBITDA (TTM)
-$70.78M
EBIT (TTM)
-$80.90M
Net Income (TTM)
-$73.88M
Balance Sheet
Total Assets (Q)
$242.84M
Total Debt (Q)
$41.87M
Total Liabilities (Q)
$71.42M
Book Value Per Share (Q)
$1.93
Cash Flow
Cash from Operations (TTM)
-$60.50M
Cash from Investing (TTM)
-$34.37M
Cash from Financing (TTM)
$69.04M
Net Change in Cash (TTM)
-$25.83M
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
2.15
7-Day Total Return
-16.32%
30-Day Total Return
-9.02%
60-Day Total Return
43.77%
90-Day Total Return
92.96%
Year to Date Total Return
39.87%
1-Year Total Return
129.58%
2-Year Total Return
526.43%
3-Year Total Return
224.81%
5-Year Total Return
-74.68%
52-week Low
Apr 07, 2025 - $2.83
52-week High
Nov 26, 2025 - $11.40
Valuation
Market Cap
$778.81M - Small Cap
Enterprise Value
$670.17M
Price/Sales (TTM)
11.26
Price/Book (Q)
4.54
Dividends and Shares
Shares Outstanding
88.70
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.personalis.com
Phone Number
650 752 1300
Address
6600 Dumbarton Circle
Fremont, CA 94555
Country
United States
Year Founded
2011
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy... more
NASDAQ 12/12/2025 4:00PM Eastern Quotes delayed